Clinical Trials
7
Active:1
Completed:4
Trial Phases
1 Phases
Not Applicable:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
7 (100.0%)Adding Printed CBT Materials to a Pediatric Digital Intervention
Not Applicable
Not yet recruiting
- Conditions
- Emotional Regulation
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2024-08-30
- Lead Sponsor
- Neuromotion Labs
- Target Recruit Count
- 150
- Registration Number
- NCT06580496
Open Label Mightier Play in the Home
Not Applicable
Completed
- Conditions
- Emotional Regulation
- First Posted Date
- 2022-12-15
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Neuromotion Labs
- Target Recruit Count
- 2732
- Registration Number
- NCT05652114
- Locations
- 🇺🇸
Neuromotion Inc, Boston, Massachusetts, United States
Mightier Play and Caregiver Stress and Wellbeing
Not Applicable
Completed
- Conditions
- Stress
- First Posted Date
- 2022-12-15
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Neuromotion Labs
- Target Recruit Count
- 392
- Registration Number
- NCT05652127
- Locations
- 🇺🇸
Neuromotion Inc, Boston, Massachusetts, United States
Examining the Impacts on In-School Behaviors of In-Home Videogame Play
Not Applicable
- Conditions
- Irritable MoodProblem BehaviorEmotional Regulation
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2022-06-09
- Lead Sponsor
- Neuromotion Labs
- Target Recruit Count
- 43
- Registration Number
- NCT05260398
- Locations
- 🇺🇸
Neuromotion Labs, Boston, Massachusetts, United States
Examining the Impacts of Parent Mightier Play
Not Applicable
Completed
- Conditions
- Emotional Regulation
- First Posted Date
- 2021-10-18
- Last Posted Date
- 2022-06-09
- Lead Sponsor
- Neuromotion Labs
- Target Recruit Count
- 41
- Registration Number
- NCT05080647
- Locations
- 🇺🇸
Neuromotion Labs, Boston, Massachusetts, United States
- Prev
- 1
- 2
- Next
News
No news found